Glycerol-3-phosphate acyltransferase-1 upregulation by O-GlcNAcylation of Sp1 protects against hypoxia-induced mouse embryonic stem cell apoptosis via mTOR activation

Cell Death and Disease

Volumn 7, Issue 3, 2016, Pages

  Lee, H J ^a   Ryu, J M ^b   Jung, Y H ^a   Lee, K H ^a   Kim, D I ^a   Han, H J ^a  

^a Seoul National University   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 1; MAMMALIAN TARGET OF RAPAMYCIN; N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; RAPAMYCIN; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; LIPID METABOLISM; MALE; MOUSE; MOUSE EMBRYONIC STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKIN FLAP SURVIVAL; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL NUCLEUS; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; GLYCOSYLATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; SKIN DISEASES; TRANSPLANTATION;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELL NUCLEUS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GLUCOSAMINE; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; GLYCOSYLATION; MICE; MOUSE EMBRYONIC STEM CELLS; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIROLIMUS; SKIN DISEASES; SP1 TRANSCRIPTION FACTOR; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84985905293     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.410     Document Type: Article

References (78)

1. Simon MC, Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 2008; 9: 285-296.
2. Ito K, Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol 2014; 15: 243-256.
3. Forsyth NR, Musio A, Vezzoni P, Simpson AH, Noble BS, McWhir J. Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells 2006; 8: 16-23.
4. Theus MH, Wei L, Cui L, Francis K, Hu X, Keogh C et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol 2008; 210: 656-670.
5. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009; 5: 237-241.
6. Song H, Cha MJ, Song BW, Kim IK, Chang W, Lim S et al. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 2010; 28: 555-563.
7. Csete M. Oxygen in the cultivation of stem cells. Ann N Y Acad Sci 2005; 1049: 1-8.
8. Holbrook NJ, Ikeyama S. Age-related decline in cellular response to oxidative stress: links to growth factor signaling pathways with common defects. Biochem Pharmacol 2002; 64: 999-1005.
9. Kumar S, Ashraf M. Tadalafil, a phosphodiesterase inhibitor protects stem cells over longer period against hypoxia/reoxygenation injury through STAT3/PKG-I signaling. Stem Cells Dev 2015; 24: 1332-1341.
10. Teslaa T, Teitell MA. Pluripotent stem cell energy metabolism: an update. EMBO J 2015; 34: 138-153.
11. Lee HJ, Ryu JM, Jung YH, Oh SY, Lee SJ, Han HJ. Novel pathway for hypoxia-induced proliferation and migration in human mesenchymal stem cells: involvement of HIF-1α, FASN, and mTORC1. Stem Cells 2015; 33: 2182-2195.
12. Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 2001; 291: 2376-2378.
13. Hart GW, Housley MP, Slawson C. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007; 446: 1017-1022.
14. Love DC, Hanover JA. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005; 2005: re13.
15. Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, Berthezene P et al. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc Natl Acad Sci USA 2013; 110: 3919-3924.
16. Dorfman A, Roseman S, Moses FE, Ludowieg J, Mayeda M. The biosynthesis of hyaluronic acid by group A Streptococcus. II. Origin of the N-acetylglucosamine moiety. J Biol Chem 1955; 212: 583-591.
17. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991; 266: 4706-4712.
18. Ghosh S, Blumenthal HJ, Davidson E, Roseman S. Glucosamine metabolism. V Enzymatic synthesis of glucosamine 6-phosphate. J Biol Chem 1960; 235: 1265-1273.
19. Shafi R, Iyer SP, Ellies LG, O'Donnell N, Marek KW, Chui D et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA 2000; 97: 5735-5739.
20. Jeon JH, Suh HN, Kim MO, Han HJ. Glucosamine-induced reduction of integrin β4 and plectin complex stimulates migration and proliferation in mouse embryonic stem cells. Stem Cells Dev 2013; 22: 2975-2989.
21. Zafir A, Readnower R, Long BW, McCracken J, Aird A, Alvarez A et al. Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells 2013; 31: 765-775.
22. Liu J, Pang Y, Chang T, Bounelis P, Chatham JC, Marchase RB. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol Cell Cardiol 2006; 40: 303-312.
23. Hardiville S, Hart GW. Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab 2014; 20: 208-213.
24. Ruan HB, Singh JP, Li MD, Wu J, Yang X. Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metab 2013; 24: 301-309.
25. Ito K, Carracedo A, Weiss D, Arai F, Ala U, Avigan DE et al. A PML-PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat Med 2012; 18: 1350-1358.
26. Folmes CD, Park S, Terzic A. Lipid metabolism greases the stem cell engine. Cell Metab 2013; 17: 153-155.
27. O'Shea KS. Self-renewal vs. differentiation of mouse embryonic stem cells. Biol Reprod 2004; 71: 1755-1765.
28. Chambers I. The molecular basis of pluripotency in mouse embryonic stem cells. Cloning Stem Cells 2004; 6: 386-391.
29. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008; 132: 661-680.
30. Lee KB, Choi J, Cho SB, Chung JY, Moon ES, Kim NS et al. Topical embryonic stem cells enhance wound healing in diabetic rats. J Orthop Res 2011; 29: 1554-1562.
31. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004; 287: H471-H479.
32. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-1024.
33. Koay EJ, Athanasiou KA. Hypoxic chondrogenic differentiation of human embryonic stem cells enhances cartilage protein synthesis and biomechanical functionality. Osteoarthritis Cartilage 2008; 16: 1450-1456.
34. Khan WS, Adesida AB, Hardingham TE. Hypoxic conditions increase hypoxia-inducible transcription factor 2α and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther 2007; 9: R55.
35. Arnaboldi PM, Behr MJ, Metzger DW. Mucosal B cell deficiency in IgA-/- mice abrogates the development of allergic lung inflammation. J Immunol 2005; 175: 1276-1285.
36. Pouwels MJ, Jacobs JR, Span PN, Lutterman JA, Smits P, Tack CJ. Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab 2001; 86: 2099-2103.
37. Mishra OP, Randis T, Ashraf QM, Delivoria-Papadopoulos M. Hypoxia-induced Bax and Bcl-2 protein expression, caspase-9 activation, DNA fragmentation, and lipid peroxidation in mitochondria of the cerebral cortex of newborn piglets: the role of nitric oxide. Neuroscience 2006; 141: 1339-1349.
38. Chen YJ, Huang YS, Chen JT, Chen YH, Tai MC, Chen CL et al. Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury. Invest Ophthalmol Vis Sci 2015; 56: 1506-1516.
39. Linington C, Hohlfeld R. T-cell mediated autoimmunity: molecular interactions and therapeutic implications. J Autoimmun 1990; 3: 501-506.
40. Jeon JH, Suh HN, Kim MO, Ryu JM, Han HJ. Glucosamine-induced OGTactivation mediates glucose production through cleaved Notch1 and FoxO1, which coordinately contributed to the regulation of maintenance of self-renewal in mouse embryonic stem cells. Stem Cells Dev 2014; 23: 2067-2079.
41. Lima VV, Spitler K, Choi H, Webb RC, Tostes RC. O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? Clin Sci (Lond) 2012; 123: 473-486.
42. Singh LP, Cheng DW, Kowluru R, Levi E, Jiang Y. Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: effect of the anti-oxidant α-lipoic acid. Cell Biochem Funct 2007; 25: 537-550.
43. Speakman CM, Domke TC, Wongpaiboonwattana W, Sanders K, Mudaliar M, van Aalten DM et al. Elevated O-GlcNAc levels activate epigenetically repressed genes and delay mouse ESC differentiation without affecting naive to primed cell transition. Stem Cells 2014; 32: 2605-2615.
44. Jang H, Kim TW, Yoon S, Choi SY, Kang TW, Kim SY et al. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 2012; 11: 62-74.
45. Song C, Song C, Tong F. Autophagy induction is a survival response against oxidative stress in bone marrow-derived mesenchymal stromal cells. Cytotherapy 2014; 16: 1361-1370.
46. Gutierrez-Uzquiza A, Arechederra M, Bragado P, Aguirre-Ghiso JA, Porras A. p38α mediates cell survival in response to oxidative stress via induction of antioxidant genes: effect on the p70S6K pathway. J Biol Chem 2012; 287: 2632-2642.
47. Ferrer CM, Lynch TP, Sodi VL, Falcone JN, Schwab LP, Peacock DL et al. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol Cell 2014; 54: 820-831.
48. Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 2008; 68: 1003-1011.
49. Rankin EB, Rha J, Selak MA, Unger TL, Keith B, Liu Q et al. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 2009; 29: 4527-4538.
50. Ben-David U, Gan QF, Golan-Lev T, Arora P, Yanuka O, Oren YS et al. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell 2013; 12: 167-179.
51. Pebay A, Bonder CS, Pitson SM. Stem cell regulation by lysophospholipids. Prostaglandins Other Lipid Mediat 2007; 84: 83-97.
52. Foster DA Phosphatidic acid and lipid-sensing by mTOR. Trends Endocrinol Metab 2013; 24: 272-278.
53. Gonzalez-Baro MR, Lewin TM, Coleman RA. Regulation of triglyceride metabolism. II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action. Am J Physiol Gastrointest Liv Physiol 2007; 292: G1195-G1199.
54. Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 2004; 43: 134-176.
55. Sul HS, Wang D. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr 1998; 18: 331-351.
56. Wendel AA, Cooper DE, Ilkayeva OR, Muoio DM, Coleman RA. Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation. J Biol Chem 2013; 288: 27299-27306.
57. Ohba Y, Sakuragi T, Kage-Nakadai E, Tomioka NH, Kono N, Imae R et al. Mitochondria-type GPAT is required for mitochondrial fusion. EMBO J 2013; 32: 1265-1279.
58. Hammond LE, Albright CD, He L, Rusyn I, Watkins SM, Doughman SD et al. Increased oxidative stress is associated with balanced increases in hepatocyte apoptosis and proliferation in glycerol-3-phosphate acyltransferase-1 deficient mice. Exp Mol Pathol 2007; 82: 210-219.
59. Liu J, Li T, Yang D, Ma R, Moran TH, Smith WW. Synphilin-1 alters metabolic homeostasis in a novel Drosophila obesity model. Int J Obes (Lond) 2012; 36: 1529-1536.
60. Solomon SS, Majumdar G, Martinez-Hernandez A, Raghow R. A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones. Life Sci 2008; 83: 305-312.
61. Zhang X, Yang R, Jia Y, Cai D, Zhou B, Qu X et al. Hypermethylation of Sp1 binding site suppresses hypothalamic POMC in neonates and may contribute to metabolic disorders in adults: impact of maternal dietary CLAs. Diabetes 2014; 63: 1475-1487.
62. Chen S, Nagy PL, Zalkin H. Role of NRF-1 in bidirectional transcription of the human GPAT-AIRC purine biosynthesis locus. Nucleic Acids Res 1997; 25: 1809-1816.
63. Schaffer SW, Croft CB, Solodushko V. Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol 2000; 278: H1948-H1954.
64. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am J Physiol Cell Physiol 2007; 292: C178-C187.
65. Goldberg HJ, Scholey J, Fantus IG. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 2000; 49: 863-871.
66. Kudlow JE Post-translational modification by O-GlcNAc: another way to change protein function. J Cell Biochem 2006; 98: 1062-1075.
67. Dottori M, Leung J, Turnley AM, Pebay A. Lysophosphatidic acid inhibits neuronal differentiation of neural stem/progenitor cells derived from human embryonic stem cells. Stem Cells 2008; 26: 1146-1154.
68. Ortlepp C, Steudel C, Heiderich C, Koch S, Jacobi A, Ryser M et al. Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation. Exp Hematol 2013; 41: 444-61.e4.
69. Costa M, Sourris K, Lim SM, Yu QC, Hirst CE, Parkington HC et al. Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localization. Stem Cell Res 2013; 10: 103-117.
70. Liu X, Hou J, Shi L, Chen J, Sang J, Hu S et al. Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo. Stem Cells Dev 2009; 18: 947-954.
71. You JS, Frey JW, Hornberger TA. Mechanical stimulation induces mTOR signaling via an ERK-independent mechanism: implications for a direct activation of mTOR by phosphatidic acid. Plos One 2012; 7: e47258.
72. Mungamuri SK, Yang X, Thor AD, Somasundaram K. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res 2006; 66: 4715-4724.
73. Kumar D, Shankar S, Srivastava RK. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett 2014; 343: 179-189.
74. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J et al. Activation of the PTEN/mTOR/ STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA 2007; 104: 16158-16163.
75. Marinov M, Ziogas A, Pardo OE, Tan LT, Dhillon T, Mauri FA et al. AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001. Clin Cancer Res 2009; 15: 1277-1287.
76. Morimoto A, Tomita S, Imanishi M, Shioi G, Kihira Y, Izawa-Ishizawa Y et al. Overexpressed HIF-2α in endothelial cells promotes vascularization and improves random pattern skin flap survival. Plast Reconstr Surg Glob Open 2014; 2: e132.
77. Basu G, Downey H, Guo S, Israel A, Asmar A, Hargrave B et al. Prevention of distal flap necrosis in a rat random skin flap model by gene electro transfer delivering VEGF(165) plasmid. J Gene Med 2014; 16: 55-65.
78. de Carvalho EN, Ferreira LM, de Carvalho NA, Alba LE, Liebano RE. Viability of a random pattern dorsal skin flap, in diabetic rats. Acta Cir Bras 2005; 20: 225-228.